Study Responsible Physician- Neuroscience (pediatric Studies)

Johnson & Johnson Johnson & Johnson · Pharma · Allschwil, Basel-Country, Switzerland

Johnson & Johnson is seeking a Study Responsible Physician for Neuroscience (Pediatric Studies) based in Allschwil, Switzerland. This role involves providing medical leadership for pediatric clinical studies in Neuroscience, contributing to clinical development plans, designing protocols, overseeing patient safety, and collaborating with cross-functional teams for regulatory submissions. The position requires an MD with experience in neuroscience and pediatric drug development, clinical trial experience, and knowledge of GCP and regulatory requirements.

What you'd actually do

  1. Responsible for medical monitoring/reporting and company safety officer activities
  2. Works on clinical development plans, trial protocols and takes ownership of clinical study reports
  3. Evaluates adverse events (pre- and post-marketing) for relationship to treatment
  4. Assists Regulatory Affairs in determining requirements for any corrective actions or health authority reporting related to study conduct or outcome
  5. May act as a medical contact at the company for health authorities concerning clinical/medical issues

Skills

Required

  • MD (or equivalent) in relevant area
  • Training or experience in neuroscience
  • Experience and knowledge of Good Clinical Practices
  • regulatory requirements for the conduct of clinical trials
  • Solid analytical and critical thinking skills
  • Strong communication and presentation skills

Nice to have

  • MD/PhD
  • child & adolescent psychiatry
  • neurology
  • neurodevelopmental disorders
  • Minimum of 1 year of experience conducting clinical trials in pharmaceutical, biotechnology, or CRO settings, with direct involvement in pediatric populations
  • Minimum of 2 years of experience conducting clinical trials in an academic setting, with some focus on pediatric or adolescent patient populations
  • ability to interpret and leverage data for decision making

What the JD emphasized

  • pediatric drug development
  • pediatric populations
  • pediatric development regulatory strategy